Hyfé, a climate-tech company unlocking low-cost production of sustainable essential goods, today announced it has scaled production of its mycelium protein to 400L pilot bioreactors since its launch and pre-seed funding last May.

Hyfé is transforming food manufacturing waste streams into fermentation feedstock. Biomanufacturing has the potential to create solutions to some of the most pressing challenges facing humanity. It can enable improvements in health, climate, and quality of life if rendered economically viable. Reducing the cost of production is key to making sustainable bioproducts competitive against subsidized commodities. The feedstocks that power bioproduction represent a high-impact opportunity since they account for up to 50% of fermentation operating expenses and are vulnerable to supply chain disruptions.

Founded in 2021 by former LanzaTech and ExxonMobil engineers, Hyfé is supported by Boston Bioworks and the University of Illinois Bioprocessing Research Laboratory. The Engine, the venture firm spun out of MIT that invests in early-stage Tough Tech companies, led the company’s recent, oversubscribed investment round.

Check out the full article on Business Wire!